Document is current
Any future updates will be listed below
-
Authors
Hofmann, Anna
Blum, Corinna
Single, Constanze
Adeyemi, Kamal
Schwarz, Patricia
Siokas, Vasileios
Rattay, Tim W.
Häberle, Helene A.
Riessen, Reimer
Brendel, Bettina
Haug, Iris
Bösel, Ruth
Zago, Manola
Martus, Peter
Ziemann, Ulf
Mengel, Annerose
Feil, Katharina
-
Funding
Funding for this research was provided by:
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 3 April 2023
Accepted: 27 July 2023
First Online: 22 August 2023
Declarations
:
: Katharina Feil and Annerose Mengel are funded by AKF (“Angewandte Klinische Forschung” = applied clinical research) grant of the medical faculty of Tübingen University (No. 496-0-0). Katharina Feil received speaker honoraria from Pfizer, study funding for Lexi Study (Boehringer Ingelheim). The remaining authors have no conflicts of interest to declare. AH: None. CB: None. CS: None. KA: None. PS: None. VS: None. TWR: None. HAH: None. RR: None. BB: None. IH: None. RB: None. MZ: None. PM: None. UZ: None. AM: None. KF: Received speaker honoraria from Pfizer, study funding for Lexi Study (Boehringer Ingelheim)
: The study protocol has been approved by the local Clinical Research Ethics Committee of the University Hospital Tuebingen and has been registered at ClinicalTrials.gov with the number NCT05479032. The study will follow the ethical principles for medical research involving human subjects of the Declaration of Helsinki, adopted by the 18th General Assembly of the World Medical Association (World Medical Association, 1964). All subjects and/or their proxies will provide informed consent to participate.
: Not applicable.
